Chimeric Antigen Receptor, Teamwork, Education, Assessment, and Management (CAR-TEAM): A Simulation-Based Inter-professional Education (IPE) Intervention for Management of CAR Toxicities

Chimeric antigen receptor (CAR) therapies such as tisagenlecleucel, indicated for children and young adults with relapsed and/or refractory CD19(+) acute lymphoblastic leukemia (ALL), have been associated with striking treatment outcomes and overall survival. Yet, they are also associated with uniqu...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Front Oncol
Autors principals: Harden, Avis, Ragoonanan, Dristhi, Anildes-Gubman, Daryl, McCall, David, Faltus, Kathleen, Featherston, Sarah, Shoberu, Basirat, Moffet, Jerelyn R., Petropoulos, Demetrios, Khazal, Sajad J., Razvi, Shehla, Mahadeo, Kris M., Tewari, Priti
Format: Artigo
Idioma:Inglês
Publicat: Frontiers Media S.A. 2020
Matèries:
Oncology
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7419673/
https://ncbi.nlm.nih.gov/pubmed/32850365
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fonc.2020.01227
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars